Title	Publication Date	Language	Citations
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors	2019/12/01	English	65
Doxorubicin cardiotoxicity and target cells: a broader perspective	2016/03/03	English	44
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series	2019/01/29	English	34
5-FU induced cardiotoxicity: case series and review of the literature	2019/09/06	English	34
Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia	2015/12/01	English	28
Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures	2016/02/25	English	27
Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic	2016/04/19	English	27
Takotsubo cardiomyopathy in cancer patients	2019/07/01	English	27
Etiology and management of hypertension in patients with cancer	2021/04/06	English	24
Hypertension in cancer patients treated with anti-angiogenic based regimens	2015/12/01	English	20
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents	2016/03/15	English	20
Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy	2020/11/05	English	19
Low dose radiation and circulatory diseases: a brief narrative review	2015/11/26	English	18
A new classification of cardio-oncology syndromes	2021/06/21	English	17
Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin	2020/01/02	English	17
Increased skeletal intermuscular fat is associated with reduced exercise capacity in cancer survivors: a cross-sectional study	2019/05/03	English	16
Cardiac safety of afatinib: a review of data from clinical trials	2015/11/26	English	16
Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development	2017/06/30	English	15
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group	2019/10/28	English	15
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey	2020/11/27	English	14
High intensity exercise during breast cancer chemotherapy - effects on long-term myocardial damage and physical capacity - data from the OptiTrain RCT	2021/02/15	English	14
Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases	2021/08/09	English	14
An international survey of healthcare providers’ knowledge of cardiac complications of cancer treatments	2019/09/02	English	14
Cardiotoxicity risk factors with immune checkpoint inhibitors	2022/03/11	English	13
Cardiovascular co-morbidity in cancer patients: the role of psychological distress	2016/11/15	English	13
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series	2021/03/30	English	12
Systemic and cardiac susceptibility of immune compromised mice to doxorubicin	2019/04/25	English	12
Management of atrial fibrillation in patients taking targeted cancer therapies	2017/03/09	English	12
A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors	2021/05/28	English	11
Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series	2020/09/23	English	11